Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys

M. Genescà, P. J. Skinner, K. M. Bost, D. Lu, Y. Wang, T. L. Rourke, A. T. Haase, M. B. McChesney, Chris J Miller

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Live attenuated lentivirus immunization is the only vaccine strategy that elicits consistent protection against intravaginal challenge with pathogenic simian immunodeficiency virus (SIV). To determine the mechanism of protection in rhesus monkeys infected with attenuated simian-human immunodeficiency virus (SHIV)89.6, a detailed analysis of SIV Gag-specific T-cell responses in several tissues including the genital tract was performed. Six months after SHIV infection, antiviral T-cell responses were rare in the cervix; however, polyfunctional, cytokine-secreting, and degranulating SIV Gag-specific CD4+ T cells were consistently found in the vagina of the immunized macaques. SIV-specific CD8+ T cells were also detected in the vagina, blood, and genital lymph nodes of most of the animals. Thus, an attenuated SHIV vaccine induces persistent antiviral T cells in tissues, including the vagina, where these effector T-cell responses may mediate the consistent protection from vaginal SIV challenge observed in this model.

Original languageEnglish (US)
Pages (from-to)219-228
Number of pages10
JournalMucosal Immunology
Volume1
Issue number3
DOIs
StatePublished - May 2008

Fingerprint

Simian Immunodeficiency Virus
Lentivirus
Macaca mulatta
Immunization
T-Lymphocytes
Vagina
HIV
Antiviral Agents
Vaccines
Macaca
Virus Diseases
Cervix Uteri
Lymph Nodes
Cytokines

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys. / Genescà, M.; Skinner, P. J.; Bost, K. M.; Lu, D.; Wang, Y.; Rourke, T. L.; Haase, A. T.; McChesney, M. B.; Miller, Chris J.

In: Mucosal Immunology, Vol. 1, No. 3, 05.2008, p. 219-228.

Research output: Contribution to journalArticle

Genescà, M, Skinner, PJ, Bost, KM, Lu, D, Wang, Y, Rourke, TL, Haase, AT, McChesney, MB & Miller, CJ 2008, 'Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys', Mucosal Immunology, vol. 1, no. 3, pp. 219-228. https://doi.org/10.1038/mi.2008.6
Genescà, M. ; Skinner, P. J. ; Bost, K. M. ; Lu, D. ; Wang, Y. ; Rourke, T. L. ; Haase, A. T. ; McChesney, M. B. ; Miller, Chris J. / Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys. In: Mucosal Immunology. 2008 ; Vol. 1, No. 3. pp. 219-228.
@article{7b5ed53c96284fe6bc5f28f990acb721,
title = "Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys",
abstract = "Live attenuated lentivirus immunization is the only vaccine strategy that elicits consistent protection against intravaginal challenge with pathogenic simian immunodeficiency virus (SIV). To determine the mechanism of protection in rhesus monkeys infected with attenuated simian-human immunodeficiency virus (SHIV)89.6, a detailed analysis of SIV Gag-specific T-cell responses in several tissues including the genital tract was performed. Six months after SHIV infection, antiviral T-cell responses were rare in the cervix; however, polyfunctional, cytokine-secreting, and degranulating SIV Gag-specific CD4+ T cells were consistently found in the vagina of the immunized macaques. SIV-specific CD8+ T cells were also detected in the vagina, blood, and genital lymph nodes of most of the animals. Thus, an attenuated SHIV vaccine induces persistent antiviral T cells in tissues, including the vagina, where these effector T-cell responses may mediate the consistent protection from vaginal SIV challenge observed in this model.",
author = "M. Genesc{\`a} and Skinner, {P. J.} and Bost, {K. M.} and D. Lu and Y. Wang and Rourke, {T. L.} and Haase, {A. T.} and McChesney, {M. B.} and Miller, {Chris J}",
year = "2008",
month = "5",
doi = "10.1038/mi.2008.6",
language = "English (US)",
volume = "1",
pages = "219--228",
journal = "Mucosal Immunology",
issn = "1933-0219",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys

AU - Genescà, M.

AU - Skinner, P. J.

AU - Bost, K. M.

AU - Lu, D.

AU - Wang, Y.

AU - Rourke, T. L.

AU - Haase, A. T.

AU - McChesney, M. B.

AU - Miller, Chris J

PY - 2008/5

Y1 - 2008/5

N2 - Live attenuated lentivirus immunization is the only vaccine strategy that elicits consistent protection against intravaginal challenge with pathogenic simian immunodeficiency virus (SIV). To determine the mechanism of protection in rhesus monkeys infected with attenuated simian-human immunodeficiency virus (SHIV)89.6, a detailed analysis of SIV Gag-specific T-cell responses in several tissues including the genital tract was performed. Six months after SHIV infection, antiviral T-cell responses were rare in the cervix; however, polyfunctional, cytokine-secreting, and degranulating SIV Gag-specific CD4+ T cells were consistently found in the vagina of the immunized macaques. SIV-specific CD8+ T cells were also detected in the vagina, blood, and genital lymph nodes of most of the animals. Thus, an attenuated SHIV vaccine induces persistent antiviral T cells in tissues, including the vagina, where these effector T-cell responses may mediate the consistent protection from vaginal SIV challenge observed in this model.

AB - Live attenuated lentivirus immunization is the only vaccine strategy that elicits consistent protection against intravaginal challenge with pathogenic simian immunodeficiency virus (SIV). To determine the mechanism of protection in rhesus monkeys infected with attenuated simian-human immunodeficiency virus (SHIV)89.6, a detailed analysis of SIV Gag-specific T-cell responses in several tissues including the genital tract was performed. Six months after SHIV infection, antiviral T-cell responses were rare in the cervix; however, polyfunctional, cytokine-secreting, and degranulating SIV Gag-specific CD4+ T cells were consistently found in the vagina of the immunized macaques. SIV-specific CD8+ T cells were also detected in the vagina, blood, and genital lymph nodes of most of the animals. Thus, an attenuated SHIV vaccine induces persistent antiviral T cells in tissues, including the vagina, where these effector T-cell responses may mediate the consistent protection from vaginal SIV challenge observed in this model.

UR - http://www.scopus.com/inward/record.url?scp=42149098404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42149098404&partnerID=8YFLogxK

U2 - 10.1038/mi.2008.6

DO - 10.1038/mi.2008.6

M3 - Article

C2 - 19079181

AN - SCOPUS:42149098404

VL - 1

SP - 219

EP - 228

JO - Mucosal Immunology

JF - Mucosal Immunology

SN - 1933-0219

IS - 3

ER -